Stock Track | Staar Surgical Soars 5.24% Intraday on Strong Preliminary Earnings and Market Recovery

Stock Track04-10

Staar Surgical's stock soared 5.24% intraday on Friday, continuing its positive momentum from the previous session.

The surge follows the company's release of a preliminary earnings report after the market close on April 8, which indicated first-quarter 2026 net sales are expected to exceed $90 million, more than doubling the sales from the same period last year and significantly beating analyst estimates. This guidance confirms the company's turnaround from a challenging 2025.

Key drivers include the completion of inventory destocking in the Chinese market, allowing shipments to resume, the launch of the next-generation EVO+ ICL (V5) in China, and an FDA age extension for its EVO ICL in the U.S. market, expanding the potential patient pool. Additionally, short covering may have amplified the price movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192708585?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-10 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192708585","market":"nz","top_or_hot":-1,"title":"Stock Track | Staar Surgical Soars 5.24% Intraday on Strong Preliminary Earnings and Market Recovery","media":"Stock Track","content":"<p>Staar Surgical's stock soared 5.24% intraday on Friday, continuing its positive momentum from the previous session.</p><p>The surge follows the company's release of a preliminary earnings report after the market close on April 8, which indicated first-quarter 2026 net sales are expected to exceed $90 million, more than doubling the sales from the same period last year and significantly beating analyst estimates. This guidance confirms the company's turnaround from a challenging 2025.</p><p>Key drivers include the completion of inventory destocking in the Chinese market, allowing shipments to resume, the launch of the next-generation EVO+ ICL (V5) in China, and an FDA age extension for its EVO ICL in the U.S. market, expanding the potential patient pool. Additionally, short covering may have amplified the price movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Staar Surgical Soars 5.24% Intraday on Strong Preliminary Earnings and Market Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Staar Surgical Soars 5.24% Intraday on Strong Preliminary Earnings and Market Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-10 22:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Staar Surgical's stock soared 5.24% intraday on Friday, continuing its positive momentum from the previous session.</p><p>The surge follows the company's release of a preliminary earnings report after the market close on April 8, which indicated first-quarter 2026 net sales are expected to exceed $90 million, more than doubling the sales from the same period last year and significantly beating analyst estimates. This guidance confirms the company's turnaround from a challenging 2025.</p><p>Key drivers include the completion of inventory destocking in the Chinese market, allowing shipments to resume, the launch of the next-generation EVO+ ICL (V5) in China, and an FDA age extension for its EVO ICL in the U.S. market, expanding the potential patient pool. Additionally, short covering may have amplified the price movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"","article_id":"1192708585","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192708585","pubTimestamp":1775831831,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Staar Surgical's stock soared 5.24% intraday on Friday, continuing its positive momentum from the previous session.The surge follows the company's release of a preliminary earnings report after the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company"},"translate_title":"个股追踪|Staar Surgical盘中大涨5.24%因初步财报强劲及市场复苏","themeId":"40c55708269c8fdd426cc05dfae7d745","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1},"content_text":"Staar Surgical's stock soared 5.24% intraday on Friday, continuing its positive momentum from the previous session.The surge follows the company's release of a preliminary earnings report after the market close on April 8, which indicated first-quarter 2026 net sales are expected to exceed $90 million, more than doubling the sales from the same period last year and significantly beating analyst estimates. This guidance confirms the company's turnaround from a challenging 2025.Key drivers include the completion of inventory destocking in the Chinese market, allowing shipments to resume, the launch of the next-generation EVO+ ICL (V5) in China, and an FDA age extension for its EVO ICL in the U.S. market, expanding the potential patient pool. Additionally, short covering may have amplified the price movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192708585","isCrawlerRequest":true}